BWAY
BrainsWay Ltd. NASDAQ Listed Apr 17, 2019$16.00
+2.24%
vs $15.65
Mkt Cap $627.6M
52w Low $5.84
88.3% of range
52w High $17.35
50d MA $15.05
200d MA $12.44
P/E (TTM)
69.6x
EV/EBITDA
20.9x
P/B
3.9x
Debt/Equity
0.1x
ROE
—
P/FCF
20.7x
RSI (14)
49.40
ATR (14)
$0.94
Beta
0.14
50d MA
$15.05
200d MA
$12.44
Avg Volume
121.1K
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Bynet Building · Jerusalem, L3 9777518 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | BMO | — | — | — | 16.74 | -0.7% | -2.6% | +0.1% | -7.9% | -1.0% | +0.1% | — |
| Mar 11, 2026 | BMO | 0.06 | 0.14 | +133.3% | 13.77 | +0.2% | -0.2% | -0.2% | -0.4% | +0.6% | -2.1% | — |
| Nov 11, 2025 | BMO | 0.11 | 0.08 | -27.3% | 7.59 | +2.0% | +4.0% | +1.5% | -1.6% | -3.7% | -2.6% | — |
| Sep 30, 2025 | BMO | — | 0.05 | — | 7.54 | -1.9% | +0.8% | -1.8% | +2.7% | -0.5% | +0.0% | — |
| May 13, 2025 | BMO | 0.02 | 0.04 | +100.0% | 4.91 | +4.3% | +4.7% | -2.9% | -0.6% | +7.5% | +0.4% | — |
| Mar 11, 2025 | BMO | 0.05 | 0.08 | +60.0% | 4.81 | +4.0% | +7.1% | -0.8% | +0.0% | +0.0% | -0.4% | — |
| Nov 12, 2024 | BMO | 0.01 | 0.04 | +207.7% | 4.85 | +0.0% | -6.8% | +5.3% | -4.2% | +3.5% | +2.5% | — |
| Aug 6, 2024 | BMO | 0.02 | 0.04 | +100.0% | 3.45 | +4.9% | -1.2% | +0.6% | +2.0% | -2.0% | +3.5% | — |
| May 8, 2024 | BMO | 0.01 | 0.01 | +100.0% | 2.85 | +1.4% | -4.2% | -2.2% | +3.0% | -0.4% | -1.1% | — |
| Mar 6, 2024 | BMO | 0.01 | 0.01 | +100.0% | 3.09 | +1.9% | -3.6% | -0.3% | +5.4% | +0.0% | -2.9% | — |
| Nov 15, 2023 | BMO | -0.07 | -0.01 | +85.7% | 2.24 | +0.4% | +4.5% | +1.7% | +1.7% | +2.9% | +10.8% | — |
| Aug 9, 2023 | BMO | -0.17 | -0.10 | +41.2% | 1.24 | +0.8% | +8.9% | +8.9% | +2.0% | -1.3% | +3.4% | — |
| May 17, 2023 | BMO | -0.12 | -0.14 | -16.7% | 0.79 | +1.6% | +2.2% | -7.5% | +3.4% | +0.0% | -1.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20 | BTIG Research | Initiates | Buy | $18 | $15.73 | $15.85 | +0.8% | +4.9% | -2.1% | +2.5% | -0.3% | -3.3% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.77 | $13.80 | +0.2% | -0.2% | -0.2% | -0.4% | +0.6% | -2.1% |
| Jan 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.52 | $12.09 | +4.9% | +7.3% | +3.6% | -3.5% | -2.7% | -2.8% |
| Dec 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.64 | $8.82 | +2.1% | +2.5% | +0.8% | +0.2% | -2.7% | -2.5% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.89 | $8.32 | +5.4% | +1.5% | -1.6% | -3.7% | -2.6% | +2.3% |
| Nov 12 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $7.59 | $7.74 | +2.0% | +4.0% | +1.5% | -1.6% | -3.7% | -2.6% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.60 | $7.68 | +1.1% | +1.1% | +3.5% | -4.0% | +0.5% | +1.4% |
| Aug 14 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $6.35 | $6.46 | +1.7% | +1.1% | +1.1% | +14.5% | -2.6% | +2.1% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.35 | $6.46 | +1.7% | +1.1% | +1.1% | +14.5% | -2.6% | +2.1% |
| Jun 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.87 | $5.74 | -2.2% | -2.7% | -4.6% | +1.5% | -0.5% | +0.4% |
| Jun 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.23 | $5.31 | +1.5% | +5.4% | +4.0% | +2.4% | -2.7% | -4.6% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.81 | $5.00 | +4.0% | +7.1% | -0.8% | +0.0% | +0.0% | -0.4% |
| Dec 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.62 | $4.66 | +0.9% | -0.9% | +2.2% | +0.0% | -2.4% | +0.9% |
| Oct 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.03 | $5.00 | -0.6% | -1.2% | -0.2% | -3.6% | +1.3% | -0.2% |
| Oct 3 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $4.50 | $4.49 | -0.2% | +6.7% | -1.0% | -1.1% | +0.6% | +4.4% |
| Sep 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.11 | $4.05 | -1.5% | +2.7% | -1.9% | +1.4% | -2.4% | -1.2% |
| Aug 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.41 | $3.53 | +3.5% | +0.6% | +2.0% | -2.0% | +3.5% | +7.6% |
| Aug 7 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $3.45 | $3.62 | +4.9% | -1.2% | +0.6% | +2.0% | -2.0% | +3.5% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.44 | $3.35 | -2.6% | +2.9% | -8.2% | -0.9% | +3.4% | -1.2% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.85 | $2.89 | +1.4% | -4.2% | -2.2% | +3.0% | -0.4% | -1.1% |
| May 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $2.85 | $2.89 | +1.4% | -4.2% | -2.2% | +3.0% | -0.4% | -1.1% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.97 | $3.03 | +2.0% | +5.4% | +0.0% | -2.9% | -6.6% | +2.5% |
| Nov 16 | Raymond James | Downgrade | Outperform → Market Perform | — | $2.24 | $2.25 | +0.4% | +4.5% | +1.7% | +1.7% | +2.9% | +10.8% |
| Nov 16 | Oppenheimer | Maintains | Outperform → Outperform | — | $2.24 | $2.25 | +0.4% | +4.5% | +1.7% | +1.7% | +2.9% | +10.8% |
| Sep 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.13 | $2.21 | +3.8% | -2.3% | +1.4% | -7.1% | +0.5% | +2.0% |
| Sep 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.86 | $1.89 | +1.6% | -4.8% | +4.5% | -4.3% | +0.0% | +6.8% |
| Aug 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.64 | $1.66 | +1.2% | +3.7% | +0.0% | -0.6% | -3.6% | +0.6% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.60 | $1.64 | +2.5% | +1.2% | -3.7% | +5.1% | +3.7% | +0.0% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.86 | $0.90 | +4.3% | +12.1% | +8.8% | +6.7% | -1.8% | +0.0% |
| May 18 | Raymond James | Maintains | Outperform → Outperform | — | $0.79 | $0.80 | +1.6% | +2.2% | -7.5% | +3.4% | +0.0% | -1.9% |
| May 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $0.79 | $0.80 | +1.6% | +2.2% | -7.5% | +3.4% | +0.0% | -1.9% |
| Apr 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.83 | $0.85 | +2.4% | +1.2% | -0.6% | +1.8% | -0.6% | +1.5% |
| Feb 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.00 | $1.01 | +1.0% | +3.0% | +1.9% | +0.0% | -3.8% | -1.5% |
| Dec 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.89 | $0.90 | +1.1% | +3.4% | +0.5% | +2.2% | +0.6% | -0.5% |
| Nov 21 | Raymond James | Maintains | Outperform → Outperform | — | $1.01 | $1.02 | +1.0% | -5.4% | +2.1% | +2.1% | -1.5% | +0.5% |
| Nov 17 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $1.10 | $1.00 | -9.1% | -9.1% | +1.0% | -5.4% | +2.1% | +2.1% |
| Aug 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.46 | $2.54 | +3.3% | -3.7% | -0.8% | -3.0% | -1.3% | +0.0% |
| Aug 11 | Raymond James | Maintains | Outperform → Outperform | — | $2.84 | $2.94 | +3.5% | -4.2% | +1.1% | -1.5% | -1.8% | -2.6% |
| May 12 | Raymond James | Maintains | Outperform → Outperform | — | $2.96 | $2.92 | -1.4% | -13.2% | +6.2% | +1.8% | +16.9% | +2.5% |
| Mar 3 | Loop Capital | Maintains | Buy → Buy | — | $3.87 | $3.96 | +2.3% | -1.0% | -2.9% | -1.6% | +9.0% | -4.8% |
| Nov 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.68 | $3.88 | +5.4% | +3.0% | +2.6% | -2.3% | +3.7% | -9.9% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.12 | $4.06 | -1.5% | -1.7% | +0.5% | -3.7% | -3.1% | +10.5% |
| Jul 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.50 | $4.52 | +0.4% | -2.4% | +1.4% | +3.4% | -1.1% | -0.9% |
| Apr 20 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $4.46 | $4.45 | -0.2% | -7.0% | -0.5% | +1.0% | -0.7% | +7.2% |
| Mar 26 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.53 | $4.64 | +2.4% | +2.9% | -2.4% | +0.7% | -1.5% | +3.8% |
| Feb 17 | Raymond James | Maintains | Outperform → Outperform | — | $4.97 | $4.80 | -3.4% | -3.6% | -3.1% | +1.9% | +5.9% | -12.6% |
| Aug 13 | Raymond James | Maintains | Outperform → Outperform | — | $3.31 | $3.38 | +2.1% | +3.3% | +1.8% | +0.6% | -2.3% | -2.6% |
| Mar 24 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $2.99 | $3.11 | +4.0% | +5.4% | +4.8% | +2.7% | -1.8% | +4.8% |
| Mar 24 | Raymond James | Maintains | Outperform → Outperform | — | $2.99 | $3.11 | +4.0% | +5.4% | +4.8% | +2.7% | -1.8% | +4.8% |
| Nov 26 | Raymond James | Maintains | Outperform → Outperform | — | $4.70 | $4.58 | -2.6% | -3.6% | +4.0% | -1.9% | +16.9% | -3.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Moiseyev GiladOff | Chief Technology Officer | Sell | 5,000 | — | — | 53,098 | +0.07% | +4.77% |
| Jun 2, 2026 | Roth YiftachOff | Chief Scientist | Sell | 2,000 | — | — | 1,072,305 | +1.64% | -1.94% |
| Jun 2, 2026 | Roth YiftachOff | Chief Scientist | Sell | 1,000 | — | — | 1,074,305 | +1.64% | -1.94% |
| Jun 1, 2026 | Roth YiftachOff | Chief Scientist | Sell | 2,000 | — | — | 1,077,305 | +1.64% | -1.94% |
| May 26, 2026 | Mitrany Rayten Michal EtyDir | — | Sell | 7,980 | — | — | 12,500 | -2.08% | -5.70% |
| May 25, 2026 | Mitrany Rayten Michal EtyDir | — | Sell | 10,000 | — | — | 20,480 | -2.08% | -5.70% |
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Acadian Asset Management Llc | 818,272 | $11M | Added | Mar 2026 |
| 2 | Essex Investment Management Co Llc | 618,553 | $8M | Added | Mar 2026 |
| 3 | Renaissance Technologies Llc | 518,420 | $7M | Added | Mar 2026 |
| 4 | Sei Investments Co | 226,378 | $3M | Added | Mar 2026 |
| 5 | Ark Investment Management Llc | 193,686 | $3M | Added | Mar 2026 |
| 6 | Legato Capital Management Llc | 192,150 | $3M | Added | Mar 2026 |
| 7 | Cresset Asset Management, Llc | 157,462 | $2M | — | Sep 2025 |
| 8 | Morgan Stanley | 92,316 | $2M | Added | Dec 2025 |
| 9 | Two Sigma Investments, Lp | 128,187 | $2M | Added | Mar 2026 |
| 10 | Citadel Advisors Llc | 87,053 | $1M | Added | Mar 2026 |
| 11 | Ubs Group Ag | 82,142 | $1M | Added | Mar 2026 |
| 12 | Wells Fargo & Company/mn | 56,156 | $746K | New | Mar 2026 |
| 13 | Jpmorgan Chase & Co | 47,030 | $600K | Added | Mar 2026 |
| 14 | Bullseye Asset Management Llc | 41,482 | $551K | Added | Mar 2026 |
| 15 | Man Group Plc | 27,224 | $362K | Added | Mar 2026 |
| 16 | Sigma Planning Corp | 15,000 | $285K | New | Dec 2025 |
| 17 | Hrt Financial Lp | 19,751 | $262K | New | Mar 2026 |
| 18 | Nano Cap New Millennium Growth Fund L P | 11,000 | $209K | New | Dec 2025 |
| 19 | Royal Bank Of Canada | 15,490 | $206K | Added | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 15,496 | $206K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 9
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | ARK Israel Innovative Technology ETF | 96,843 | $2M | Jan 2026 |
| 2 | MEDIUM-DURATION BOND FUND | 2,300,000 | $2M | Mar 2026 |
| 3 | 1290 Essex Small Cap Growth Fund | 66,480 | $2M | Jan 2026 |
| 4 | Royce Smaller-Companies Growth Fund | 97,000 | $1M | Mar 2026 |
| 5 | Old Westbury Small & Mid Cap Strategies Fund | 50,627 | $591K | Jan 2026 |
| 6 | Empower Core Bond Fund | 395,000 | $400K | Mar 2026 |
| 7 | ActivePassive International Equity ETF | 16,664 | $386K | Feb 2026 |
| 8 | Fidelity Nasdaq Composite Index Fund | 5,012 | $116K | Feb 2026 |
| 9 | VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | 4,917 | $115K | Jan 2026 |
Valuation
Market Cap
$627.6M
Enterprise Value
$262.7M
P/E (TTM)
69.63x
Forward P/E
82.05x
PEG Ratio
0.06x
P/B
3.90x
P/S
6.04x
P/FCF
20.69x
EV/EBITDA
20.90x
Shares Out
21.2M
Financials (TTM)
Revenue
$56.2M
Net Income
$8.8M
EBITDA
$12.6M
Free Cash Flow
$16.4M
Op Cash Flow
$18.2M
EPS Basic
$0.40
EPS Diluted
$0.35
EPS Forward
$0.20
Gross Margin
75.5%
Op Margin
10.2%
Net Margin
15.7%
Balance Sheet
Total Assets
$112.9M
Total Liab.
$34.7M
Total Equity
$73.2M
Cash
$69.1M
LT Debt
$0
Book Value/Sh
$4.10
Debt/Equity
0.09x
Current Ratio
3.83
Quick Ratio
3.51
Returns & Growth
ROE
—
ROA
—
ROIC
4.7%
Rev Growth YoY
+28.3%
EPS Growth YoY
+365.1%
Price Returns
2W
-5.2%
1M
+4.5%
3M
-6.3%
6M
+43.7%
12M
+164.4%
Technicals
52W High
$17.35
52W Low
$5.84
50d MA
$15.05
200d MA
$12.44
RSI (14)
49.40
ATR (14)
$0.94
Beta
0.14
Avg Volume
121K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$15.00
High
$15.00
Low
$15.00
Median
$15.00
Data updated apr 26, 2026 10:02am
· Source: financialmodelingprep.com